Heart Rhythm
Volume 6, Issue 2 , Pages 161-168 , February 2009

Temporal left atrial lesion formation after ablation of atrial fibrillation

  • Troy J. Badger, MD

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Robert S. Oakes, BS

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Marcos Daccarett, MD

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Nathan S. Burgon, BS

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Nazem Akoum, MD

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Eric N. Fish

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Joshua J.E. Blauer, BS

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • Scientific Computing Institute, University of Utah. Salt Lake City, Utah
    • ,
  • Swati N. Rao

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Yaw Adjei-Poku, BS

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • ,
  • Eugene G. Kholmovski, PhD

      Affiliations

    • Utah Center for Advanced Radiology Research, University of Utah. Salt Lake City, Utah
    • ,
  • Sathya Vijayakumar, MS

      Affiliations

    • Utah Center for Advanced Radiology Research, University of Utah. Salt Lake City, Utah
    • ,
  • Edward V.R. Di Bella, PhD

      Affiliations

    • Utah Center for Advanced Radiology Research, University of Utah. Salt Lake City, Utah
    • ,
  • Rob S. MacLeod, PhD

      Affiliations

    • Scientific Computing Institute, University of Utah. Salt Lake City, Utah
    • ,
  • Nassir F. Marrouche, MD, FHRS

      Affiliations

    • Atrial Fibrillation Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah
    • Corresponding Author InformationAddress reprint requests and correspondence: Nassir F. Marrouche, M.D., Division of Cardiology, University of Utah Health Sciences Center, 30 North 1900 East, Room 4A100, Salt Lake City, Utah 84132-2400

Received 4 September 2008 ,Accepted 28 October 2008.

References 

  1. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216–221
  2. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation. 2003;107:2710–2716
  3. Marrouche NF, Dresing T, Cole C, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol. 2002;40:464–474
  4. Verma A, Marrouche NF, Natale A. Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol. 2004;15:1335–1340
  5. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666
  6. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000;102:2619–2628
  7. Jais P, Weerasooriya R, Shah DC, et al. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc Res. 2002;54:337–346
  8. Dickfeld T, Kato R, Zviman M, et al. Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2006;47:370–378
  9. Deneke T, Khargi K, Lemke B, et al. Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation. Eur Heart J. 2007;28:2909–2914
  10. Aupperle H, Doll N, Walther T, et al. Histological findings induced by different energy sources in experimental atrial ablation in sheep. Interact Cardiovasc Thorac Surg. 2005;4:450–455
  11. Huang SK, Bharati S, Graham AR, et al. Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy—a new method of catheter ablation. J Am Coll Cardiol. 1987;9:349–358
  12. Santiago T, Melo JQ, Gouveia RH, et al. Intra-atrial temperatures in radiofrequency endocardial ablation: histologic evaluation of lesions. Ann Thorac Surg. 2003;75:1495–1501
  13. Peters DC, Wylie JV, Hauser TH, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007;243:690–695
  14. McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging based method to define the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008;52:1263–1271
  15. Kanj MH, Wazni O, Fahmy T, et al. Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. J Am Coll Cardiol. 2007;49:1634–1641
  16. Calkins H, Brugada J, Packer DL, et al. J. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up (A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society). Europace. 2007;9:335–379
  17. Deneke T, Khargi K, Muller KM, et al. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J. 2005;26:1797–1803
  18. Oswald H, Gardiwal A, Lissel C, et al. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol. 2007;30:885–890
  19. Okada T, Yamada T, Murakami Y, et al. Prevalence and severity of left atrial edema detected by electron beam tomography early after pulmonary vein ablation. J Am Coll Cardiol. 2007;49:1436–1442
  20. Steel KE, Roman-Gonzalez J, O'Bryan CL. Images in cardiovascular medicine (Severe left atrial edema and heart failure after atrial fibrillation ablation). Circulation. 2006;113:e659
  21. Adzamli IK, Jolesz FA, Bleier AR, et al. The effect of gadolinium DTPA on tissue water compartments in slow- and fast-twitch rabbit muscles. Magn Reson Med. 1989;11:172–181
  22. Bogaert J, Taylor AM, Van Kerkhove F, et al. Use of inversion recovery contrast-enhanced MRI for cardiac imaging: spectrum of applications. AJR Am J Roentgenol. 2004;182:609–615
  23. Aso H, Takeda K, Ito T, et al. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol. 1998;33:22–32
  24. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998;97:1802–1809
  25. Gu X, Cheng L, Chueng WL, et al. Neovascularization of ischemic myocardium by newly isolated tannins prevents cardiomyocyte apoptosis and improves cardiac function. Mol Med. 2006;12:275–283
  26. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430–436
  27. Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226:316–327
  28. Gerstenfeld EP, Callans DJ, Dixit S, et al. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J Cardiovasc Electrophysiol. 2003;14:685–690
  29. Katritsis DG, Ellenbogen KA, Panagiotakos DB, et al. Ablation of superior pulmonary veins compared to ablation of all four pulmonary veins. J Cardiovasc Electrophysiol. 2004;15:641–645
  30. Cappato R, Negroni S, Pecora D, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003;108:1599–1604
  31. Nanthakumar K, Plumb VJ, Epstein AE, et al. Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy?. Circulation. 2004;109:1226–1229

 Drs. Edward V. R. DiBella, Eugene G. Kholmovski, and Nassir F. Marrouche are partially supported by grants from Siemens Medical Corporation and SurgiVision Corporation.

PII: S1547-5271(08)01079-5

doi: 10.1016/j.hrthm.2008.10.042

Heart Rhythm
Volume 6, Issue 2 , Pages 161-168 , February 2009

Article Tools

* Image Usage & Resolution